This session, chaired by Professor Mark Lawler from Queen’s University Belfast (UK), will focus on the use of health data, analytics and technology to accelerate the translation of scientific advances in cancer research and to improve access to quality care for patients. Dr Lynda Chin, a world-renowned cancer genomic scientist, from the Dell Medical School at the University of Texas at Austin (USA), has made many scientific discoveries spanning mouse models of human cancers, cancer genomics, and personalised cancer medicine. She will discuss how data, analytics and technologies enable not only precision in discovery research but also in care delivery, ushering in a new era of precision medicine. She will also share innovative models to narrow the disparity in access to care.
Who should attend?
Anyone interested or working in health data including patients and carers formally involved in research, scientists, medical/clinical oncologists, surgeons, early career researchers, nurses, allied health professionals, PhD and undergraduate students, research teams and research managers/funders